Summary
The global Direct To Consumer Disease Risk And Health Test Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Direct To Consumer Disease Risk And Health Test Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Direct To Consumer Disease Risk And Health Test Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
By the Product Type, the market is primarily segmented into:
- Celiac Disease
- Parkinson Disease
- Alzheimer Disease
- Other
- Market segment by Application, split into
- Online
- Offline
By Applications, the market is segmented into:
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Direct To Consumer Disease Risk And Health Test Market Report:
- To assess the size of the market by value and volume
- Analyze the Direct To Consumer Disease Risk And Health Test Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Direct To Consumer Disease Risk And Health Test Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Direct To Consumer Disease Risk And Health Test Market
The Direct To Consumer Disease Risk And Health Test Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Direct To Consumer Disease Risk And Health Test Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
1.4 Market Analysis by Type
1.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Celiac Disease
1.4.3 Parkinson Disease
1.4.4 Alzheimer Disease
1.4.5 Other
1.5 Market by Application
1.5.1 Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2020 VS 2026
1.5.2 Online
1.5.3 Offline
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Direct-to-consumer Disease Risk and Health Test Market Perspective (2015-2026)
2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Regions
2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Direct-to-consumer Disease Risk and Health Test Historic Market Share by Regions (2015-2020)
2.2.3 Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Direct-to-consumer Disease Risk and Health Test Market Growth Strategy
2.3.6 Primary Interviews with Key Direct-to-consumer Disease Risk and Health Test Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Market Size
3.1.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue (2015-2020)
3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2015-2020)
3.1.3 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio
3.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Test Revenue in 2019
3.3 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
3.4 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
3.5 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2015-2020)
4.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2021-2026)
5 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Application (2015-2026)
5.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
5.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
6.2 Direct-to-consumer Disease Risk and Health Test Key Players in North America (2019-2020)
6.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
6.4 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
7 Europe
7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
7.2 Direct-to-consumer Disease Risk and Health Test Key Players in Europe (2019-2020)
7.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
7.4 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
8 China
8.1 China Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
8.2 Direct-to-consumer Disease Risk and Health Test Key Players in China (2019-2020)
8.3 China Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
8.4 China Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
9 Japan
9.1 Japan Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
9.2 Direct-to-consumer Disease Risk and Health Test Key Players in Japan (2019-2020)
9.3 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
9.4 Japan Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
10.2 Direct-to-consumer Disease Risk and Health Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
10.4 Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
11 India
11.1 India Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
11.2 Direct-to-consumer Disease Risk and Health Test Key Players in India (2019-2020)
11.3 India Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
11.4 India Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size (2015-2020)
12.2 Direct-to-consumer Disease Risk and Health Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020)
12.4 Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020)
13Key Players Profiles
13.1 23andMe
13.1.1 23andMe Company Details
13.1.2 23andMe Business Overview and Its Total Revenue
13.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction
13.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020))
13.1.5 23andMe Recent Development
13.2 MyHeritage
13.2.1 MyHeritage Company Details
13.2.2 MyHeritage Business Overview and Its Total Revenue
13.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction
13.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.2.5 MyHeritage Recent Development
13.3 LabCorp
13.3.1 LabCorp Company Details
13.3.2 LabCorp Business Overview and Its Total Revenue
13.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction
13.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.3.5 LabCorp Recent Development
13.4 Myriad Genetics
13.4.1 Myriad Genetics Company Details
13.4.2 Myriad Genetics Business Overview and Its Total Revenue
13.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction
13.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.4.5 Myriad Genetics Recent Development
13.5 Ancestry.com
13.5.1 Ancestry.com Company Details
13.5.2 Ancestry.com Business Overview and Its Total Revenue
13.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction
13.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.5.5 Ancestry.com Recent Development
13.6 Quest Diagnostics
13.6.1 Quest Diagnostics Company Details
13.6.2 Quest Diagnostics Business Overview and Its Total Revenue
13.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction
13.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.6.5 Quest Diagnostics Recent Development
13.7 Gene By Gene
13.7.1 Gene By Gene Company Details
13.7.2 Gene By Gene Business Overview and Its Total Revenue
13.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction
13.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.7.5 Gene By Gene Recent Development
13.8 DNA Diagnostics Center
13.8.1 DNA Diagnostics Center Company Details
13.8.2 DNA Diagnostics Center Business Overview and Its Total Revenue
13.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction
13.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.8.5 DNA Diagnostics Center Recent Development
13.9 Invitae
13.9.1 Invitae Company Details
13.9.2 Invitae Business Overview and Its Total Revenue
13.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction
13.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.9.5 Invitae Recent Development
13.10 IntelliGenetics
13.10.1 IntelliGenetics Company Details
13.10.2 IntelliGenetics Business Overview and Its Total Revenue
13.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction
13.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
13.10.5 IntelliGenetics Recent Development
13.11 Ambry Genetics
10.11.1 Ambry Genetics Company Details
10.11.2 Ambry Genetics Business Overview and Its Total Revenue
10.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction
10.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.11.5 Ambry Genetics Recent Development
13.12 Living DNA
10.12.1 Living DNA Company Details
10.12.2 Living DNA Business Overview and Its Total Revenue
10.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction
10.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.12.5 Living DNA Recent Development
13.13 EasyDNA
10.13.1 EasyDNA Company Details
10.13.2 EasyDNA Business Overview and Its Total Revenue
10.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction
10.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.13.5 EasyDNA Recent Development
13.14 Pathway Genomics
10.14.1 Pathway Genomics Company Details
10.14.2 Pathway Genomics Business Overview and Its Total Revenue
10.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction
10.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.14.5 Pathway Genomics Recent Development
13.15 Centrillion Technology
10.15.1 Centrillion Technology Company Details
10.15.2 Centrillion Technology Business Overview and Its Total Revenue
10.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction
10.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.15.5 Centrillion Technology Recent Development
13.16 Xcode
10.16.1 Xcode Company Details
10.16.2 Xcode Business Overview and Its Total Revenue
10.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction
10.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.16.5 Xcode Recent Development
13.17 Color Genomics
10.17.1 Color Genomics Company Details
10.17.2 Color Genomics Business Overview and Its Total Revenue
10.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction
10.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.17.5 Color Genomics Recent Development
13.18 Anglia DNA Services
10.18.1 Anglia DNA Services Company Details
10.18.2 Anglia DNA Services Business Overview and Its Total Revenue
10.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
10.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.18.5 Anglia DNA Services Recent Development
13.19 African Ancestry
10.19.1 African Ancestry Company Details
10.19.2 African Ancestry Business Overview and Its Total Revenue
10.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction
10.19.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.19.5 African Ancestry Recent Development
13.20 Canadian DNA Services
10.20.1 Canadian DNA Services Company Details
10.20.2 Canadian DNA Services Business Overview and Its Total Revenue
10.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
10.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.20.5 Canadian DNA Services Recent Development
13.21 DNA Family Check
10.21.1 DNA Family Check Company Details
10.21.2 DNA Family Check Business Overview and Its Total Revenue
10.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction
10.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.21.5 DNA Family Check Recent Development
13.22 Alpha Biolaboratories
10.22.1 Alpha Biolaboratories Company Details
10.22.2 Alpha Biolaboratories Business Overview and Its Total Revenue
10.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction
10.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.22.5 Alpha Biolaboratories Recent Development
13.23 Test Me DNA
10.23.1 Test Me DNA Company Details
10.23.2 Test Me DNA Business Overview and Its Total Revenue
10.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction
10.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.23.5 Test Me DNA Recent Development
13.24 23 Mofang
10.24.1 23 Mofang Company Details
10.24.2 23 Mofang Business Overview and Its Total Revenue
10.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction
10.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.24.5 23 Mofang Recent Development
13.25 Genetic Health
10.25.1 Genetic Health Company Details
10.25.2 Genetic Health Business Overview and Its Total Revenue
10.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction
10.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.25.5 Genetic Health Recent Development
13.26 DNA Services of America
10.26.1 DNA Services of America Company Details
10.26.2 DNA Services of America Business Overview and Its Total Revenue
10.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction
10.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.26.5 DNA Services of America Recent Development
13.27 Shuwen Health Sciences
10.27.1 Shuwen Health Sciences Company Details
10.27.2 Shuwen Health Sciences Business Overview and Its Total Revenue
10.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction
10.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.27.5 Shuwen Health Sciences Recent Development
13.28 Mapmygenome
10.28.1 Mapmygenome Company Details
10.28.2 Mapmygenome Business Overview and Its Total Revenue
10.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction
10.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.28.5 Mapmygenome Recent Development
13.29 Full Genomes
10.29.1 Full Genomes Company Details
10.29.2 Full Genomes Business Overview and Its Total Revenue
10.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction
10.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020)
10.29.5 Full Genomes Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Direct-to-consumer Disease Risk and Health Test Key Market Segments
Table 2. Key Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
Table 3. Ranking of Global Top Direct-to-consumer Disease Risk and Health Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Celiac Disease
Table 6. Key Players of Parkinson Disease
Table 7. Key Players of Alzheimer Disease
Table 8. Key Players of Other
Table 9. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Direct-to-consumer Disease Risk and Health Test Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2015-2020)
Table 13. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Direct-to-consumer Disease Risk and Health Test Market Growth Strategy
Table 19. Main Points Interviewed from Key Direct-to-consumer Disease Risk and Health Test Players
Table 20. Global Direct-to-consumer Disease Risk and Health Test Revenue by Players (2015-2020) (Million US$)
Table 21. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players (2015-2020)
Table 22. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2019)
Table 23. Global Direct-to-consumer Disease Risk and Health Test by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
Table 26. Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 29. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Type (2015-2020)
Table 30. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2021-2026)
Table 31. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Application (2015-2020)
Table 32. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 33. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Application (2021-2026)
Table 34. North America Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 36. North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 37. North America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 38. North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 39. North America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 40. Europe Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 42. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 44. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 46. China Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 47. China Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 48. China Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 49. China Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 50. China Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 51. China Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 52. Japan Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 54. Japan Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 56. Japan Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 60. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 62. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 64. India Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 65. India Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 66. India Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 67. India Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 68. India Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 69. India Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Direct-to-consumer Disease Risk and Health Test Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Direct-to-consumer Disease Risk and Health Test Market Share (2019-2020)
Table 72. Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2015-2020)
Table 74. Central & South America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2015-2020)
Table 76. 23andMe Company Details
Table 77. 23andMe Business Overview
Table 78. 23andMe Product
Table 79. 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 80. 23andMe Recent Development
Table 81. MyHeritage Company Details
Table 82. MyHeritage Business Overview
Table 83. MyHeritage Product
Table 84. MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 85. MyHeritage Recent Development
Table 86. LabCorp Company Details
Table 87. LabCorp Business Overview
Table 88. LabCorp Product
Table 89. LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 90. LabCorp Recent Development
Table 91. Myriad Genetics Company Details
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Product
Table 94. Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 95. Myriad Genetics Recent Development
Table 96. Ancestry.com Company Details
Table 97. Ancestry.com Business Overview
Table 98. Ancestry.com Product
Table 99. Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 100. Ancestry.com Recent Development
Table 101. Quest Diagnostics Company Details
Table 102. Quest Diagnostics Business Overview
Table 103. Quest Diagnostics Product
Table 104. Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 105. Quest Diagnostics Recent Development
Table 106. Gene By Gene Company Details
Table 107. Gene By Gene Business Overview
Table 108. Gene By Gene Product
Table 109. Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 110. Gene By Gene Recent Development
Table 111. DNA Diagnostics Center Business Overview
Table 112. DNA Diagnostics Center Product
Table 113. DNA Diagnostics Center Company Details
Table 114. DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 115. DNA Diagnostics Center Recent Development
Table 116. Invitae Company Details
Table 117. Invitae Business Overview
Table 118. Invitae Product
Table 119. Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 120. Invitae Recent Development
Table 121. IntelliGenetics Company Details
Table 122. IntelliGenetics Business Overview
Table 123. IntelliGenetics Product
Table 124. IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 125. IntelliGenetics Recent Development
Table 126. Ambry Genetics Company Details
Table 127. Ambry Genetics Business Overview
Table 128. Ambry Genetics Product
Table 129. Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 130. Ambry Genetics Recent Development
Table 131. Living DNA Company Details
Table 132. Living DNA Business Overview
Table 133. Living DNA Product
Table 134. Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 135. Living DNA Recent Development
Table 136. EasyDNA Company Details
Table 137. EasyDNA Business Overview
Table 138. EasyDNA Product
Table 139. EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 140. EasyDNA Recent Development
Table 141. Pathway Genomics Company Details
Table 142. Pathway Genomics Business Overview
Table 143. Pathway Genomics Product
Table 144. Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 145. Pathway Genomics Recent Development
Table 146. Centrillion Technology Company Details
Table 147. Centrillion Technology Business Overview
Table 148. Centrillion Technology Product
Table 149. Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 150. Centrillion Technology Recent Development
Table 151. Xcode Company Details
Table 152. Xcode Business Overview
Table 153. Xcode Product
Table 154. Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 155. Xcode Recent Development
Table 156. Color Genomics Company Details
Table 157. Color Genomics Business Overview
Table 158. Color Genomics Product
Table 159. Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 160. Color Genomics Recent Development
Table 161. Anglia DNA Services Company Details
Table 162. Anglia DNA Services Business Overview
Table 163. Anglia DNA Services Product
Table 164. Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 165. Anglia DNA Services Recent Development
Table 166. African Ancestry Company Details
Table 167. African Ancestry Business Overview
Table 168. African Ancestry Product
Table 169. African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 170. African Ancestry Recent Development
Table 171. Canadian DNA Services Company Details
Table 172. Canadian DNA Services Business Overview
Table 173. Canadian DNA Services Product
Table 174. Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 175. Canadian DNA Services Recent Development
Table 176. DNA Family Check Company Details
Table 177. DNA Family Check Business Overview
Table 178. DNA Family Check Product
Table 179. DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 180. DNA Family Check Recent Development
Table 181. Alpha Biolaboratories Company Details
Table 182. Alpha Biolaboratories Business Overview
Table 183. Alpha Biolaboratories Product
Table 184. Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 185. Alpha Biolaboratories Recent Development
Table 186. Test Me DNA Company Details
Table 187. Test Me DNA Business Overview
Table 188. Test Me DNA Product
Table 189. Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 190. Test Me DNA Recent Development
Table 191. 23 Mofang Company Details
Table 192. 23 Mofang Business Overview
Table 193. 23 Mofang Product
Table 194. 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 195. 23 Mofang Recent Development
Table 196. Genetic Health Company Details
Table 197. Genetic Health Business Overview
Table 198. Genetic Health Product
Table 199. Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 200. Genetic Health Recent Development
Table 201. DNA Services of America Company Details
Table 202. DNA Services of America Business Overview
Table 203. DNA Services of America Product
Table 204. DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 205. DNA Services of America Recent Development
Table 206. Shuwen Health Sciences Company Details
Table 207. Shuwen Health Sciences Business Overview
Table 208. Shuwen Health Sciences Product
Table 209. Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 210. Shuwen Health Sciences Recent Development
Table 211. Mapmygenome Company Details
Table 212. Mapmygenome Business Overview
Table 213. Mapmygenome Product
Table 214. Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 215. Mapmygenome Recent Development
Table 216. Full Genomes Company Details
Table 217. Full Genomes Business Overview
Table 218. Full Genomes Product
Table 219. Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2015-2020) (Million US$)
Table 220. Full Genomes Recent Development
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Direct-to-consume
Request Discount 
Inquire Before Buy
